Literature DB >> 16965563

A peritonitis model with low mortality and persisting intra-abdominal abscesses.

Otmar R Buyne1, Robert P Bleichrodt, Paul E Verweij, Hans M M Groenewoud, Harry van Goor, Thijs Hendriks.   

Abstract

Intra-abdominal abscesses are a potential source of recurrent or residual infection after surgical intervention for secondary peritonitis. The development of therapies requires a model which combines low mortality with the formation of persisting abscesses and which is also suitable to study the local inflammatory response. Male Wistar rats were injected intraperitoneally with a mixture of sterile rat faeces, increasing doses of E. coli (10(4)-10(8) cfu/ml) and a fixed dose of B. Fragilis (10(4) cfu/ml). After one h a laparotomy was performed and the peritoneal cavity was debrided. Blood samples were taken under anaesthesia after 6 and 24 h. Abdominal fluid samples were collected (by laparotomy) after 24 and 72 h. The rats were killed after 5 days and the abdomen was inspected for abscesses. Mortality was 90% in the two groups with the highest doses of E. coli and 30% in those with the two lowest doses. In the latter groups all surviving rats but one showed intraabdominal abscesses and bacteremia was encountered frequently, especially after 24 h in the 10(5) cfu E. coli group. The groups receiving 10(4)-10(6) cfu E. coli showed similar plasma IL-6 concentrations after 6 h which were lowered significantly after 24 h. No circulating TNF-alpha was found. Considerable concentrations of TNF-alpha, IL-6, IL-1beta, and IL-10, were found in the peritoneal fluid after 24 h but no differences were observed between the contro groups and those receiving 10(4)-10(6) cfu E. coli. At 72 h cytokine levels were reduced significantly and remained the highest in the animals dosed with 10(6) cfu E. coli. The present model is suitable to study the mechanisms involved in, and prevention of, intra-abdominal abscess formation after surgical treatment of generalized peritonitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16965563      PMCID: PMC2517383          DOI: 10.1111/j.1365-2613.2006.00488.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  28 in total

1.  A rat model of non-lethal bacterial infection.

Authors:  D A Wandall; M Arpi; J H Wandall
Journal:  APMIS       Date:  1997-03       Impact factor: 3.205

2.  Local treatment of generalised peritonitis in rats; effects on bacteria, endotoxin and mortality.

Authors:  C Rosman; G J Westerveld; K Kooi; R P Bleichrodt
Journal:  Eur J Surg       Date:  1999-11

Review 3.  Peritonitis: pathophysiology and local defense mechanisms.

Authors:  R Heemken; L Gandawidjaja; T Hau
Journal:  Hepatogastroenterology       Date:  1997 Jul-Aug

4.  Lipopolysaccharide-binding protein is present in effluents of patients with Gram-negative and Gram-positive CAPD peritonitis.

Authors:  K Schäfer; R R Schumann; S Stöteknuel; P Schollmeyer; G J Dobos
Journal:  Nephrol Dial Transplant       Date:  1998-04       Impact factor: 5.992

5.  Microbiological and inflammatory effects of murine recombinant interleukin-10 in two models of polymicrobial peritonitis in rats.

Authors:  P Montravers; L Maulin; J Mohler; C Carbon
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

6.  Nitrite/nitrate oxide and cytokines changes in patients with surgical stress.

Authors:  Naoki Hirabayashi; Hiroshi Tanimura; Hiroki Yamaue
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

7.  Peritoneal cytokine concentrations and survival outcome in an experimental bacterial infusion model of peritonitis.

Authors:  L Martineau; P N Shek
Journal:  Crit Care Med       Date:  2000-03       Impact factor: 7.598

8.  Culture of human peritoneum--a new method to measure the local cytokine response and the effect of immunomodulators.

Authors:  W Haupt; J Riese; C Denzel; M Zowe; J Gusinde; M Siassi; W Hohenberger
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

Review 9.  Primary and secondary peritonitis: an update.

Authors:  M Laroche; G Harding
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 3.267

Review 10.  Epidemiology and pathophysiology of intraabdominal infections (IAI).

Authors:  E H Farthmann; U Schöffel
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

View more
  2 in total

1.  Tissue-type plasminogen activator prevents formation of intra-abdominal abscesses after surgical treatment of secondary peritonitis in a rat model.

Authors:  Otmar R Buyne; Robert P Bleichrodt; Harry van Goor; Paul E Verweij; Thijs Hendriks
Journal:  Int J Colorectal Dis       Date:  2006-11-07       Impact factor: 2.796

2.  Polyester Mesh Functionalization with Nitric Oxide-Releasing Silica Nanoparticles Reduces Early Methicillin-Resistant Staphylococcus aureus Contamination.

Authors:  Joseph S Fernandez-Moure; Jeffrey L Van Eps; Jacob C Scherba; Seth Haddix; Megan Livingston; Nathan S Bryan; Concepcion Cantu; Chandni Valson; Francesca Taraballi; Lewis J Kaplan; Randall Olsen; Ennio Tasciotti
Journal:  Surg Infect (Larchmt)       Date:  2021-04-30       Impact factor: 1.853

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.